Sepracor

This is the limited version of the Sepracor company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs. Our drug development program has yielded a portfolio of pharmaceutical products and candidates with a focus on the treatment of respiratory and central nervous system (CNS) disorders. Our commercialization efforts are carried out by our U.S.-based primary care and specialty-oriented sales force, as well as through out-licensing partnerships.

Your Connections to Sepracor

To see how you’re connected: Join Now or Sign In

Popular Profiles at Sepracor

New Hires and Recent Promotions at Sepracor

  • Michelle Petrosh, Associate Director, Research Quality Assurance

    was Senior Manager, Research Quality Assurance - this month

  • Todd Bazemore, Executive Director, Respiratory Marketing

    was Sr. Director, Respiratory Marketing - last month

  • Chris O'Konis, Senior Director, Commercial Insights & Analytics

    was Director - 2 months ago

  • Raul Oliva, Associate Director - Epilepsy Marketing

    was Senior Product Manager - ALVESCO - 2 months ago

  • Bill Fruhan, Senior Director, Commercial Insight & Analysis

    was Director, Market Insight & Analysis - 2 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by Associate Director, Commercial Insights & Analytics

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Sepracor. This page is not endorsed by or affiliated with Sepracor. For questions regarding LinkedIn Company Profiles, contact us.

Sepracor (SEPR) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions